연구성과로 돌아가기
2020 연구성과별 연구자 정보 (1641 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Ahn, J. B. | Ahn, JB | 7 | Severance Hosp, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Lee, M. A. | Lee, MA | 8 | Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Lin, J. | Lin, J | 9 | Mackay Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Ho, G. F. | Ho, GF | 10 | Univ Malaya, Med Ctr, Clin Oncol Unit, Kuala Lumpur, Malaysia | B-8634-2010 | HO, GWO FUANG | 0000-0002-2620-9174 | Ho, Gwo Fuang | ||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Anh, L. T. | Anh, LT | 11 | Cho Ray Hosp, Med Oncol, Ho Chi Minh City, Vietnam | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Temraz, S. | Temraz, S | 12 | Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Burge, M. | Burge, M | 13 | Royal Brisbane Hosp, Dept Med Oncol, Brisbane, Qld, Australia | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Chua, C. | Chua, C | 14 | Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Huang, J. | Huang, J | 15 | Merck Pte Ltd, Oncol, Singapore, Singapore | ||||||
| Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | Park, Y. S. | Park, YS | 16 | Samsung Med Ctr, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea | ||||||
| Protection against UVB-Induced Photoaging by Nypa fruticans via Inhibition of MAPK/AP-1/MMP-1 Signaling | Choi, Hee-Jeong | Choi, HJ | 1 | Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea | sang@knu.ac.kr; | |||||
| Protection against UVB-Induced Photoaging by Nypa fruticans via Inhibition of MAPK/AP-1/MMP-1 Signaling | Alam, Md Badrul | Alam, MB | 2 | Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea | AAK-7176-2021 | Alam, Md Badrul | sang@knu.ac.kr; | |||
| Protection against UVB-Induced Photoaging by Nypa fruticans via Inhibition of MAPK/AP-1/MMP-1 Signaling | Alam, Md Badrul | Alam, MB | 2 | Kyungpook Natl Univ, Inner Beauty Antiaging Ctr, Food & Bioind Res Inst, Daegu 41566, South Korea | AAK-7176-2021 | Alam, Md Badrul | sang@knu.ac.kr; | |||
| Protection against UVB-Induced Photoaging by Nypa fruticans via Inhibition of MAPK/AP-1/MMP-1 Signaling | Baek, Mi-Eun | Baek, ME | 3 | Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea | sang@knu.ac.kr; | |||||
| Protection against UVB-Induced Photoaging by Nypa fruticans via Inhibition of MAPK/AP-1/MMP-1 Signaling | Kwon, Yoon-Gyung | Kwon, YG | 4 | Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea | sang@knu.ac.kr; |
페이지 이동: